Anti-GTR6/ SLC2A6/ GLUT6 monoclonal antibody

Anti-GTR6/ SLC2A6/ GLUT6 antibody for FACS & in-vivo assay

Target products collectionGo to SLC2A6/SLC2A6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1595-Ab-1/ GM-Tg-hg-MP1595-Ab-2Anti-Human SLC2A6 monoclonal antibodyHuman
GM-Tg-rg-MP1595-Ab-1/ GM-Tg-rg-MP1595-Ab-2Anti-Rat SLC2A6 monoclonal antibodyRat
GM-Tg-mg-MP1595-Ab-1/ GM-Tg-mg-MP1595-Ab-2Anti-Mouse SLC2A6 monoclonal antibodyMouse
GM-Tg-cynog-MP1595-Ab-1/ GM-Tg-cynog-MP1595-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC2A6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1595-Ab-1/ GM-Tg-felg-MP1595-Ab-2Anti-Feline SLC2A6 monoclonal antibodyFeline
GM-Tg-cang-MP1595-Ab-1/ GM-Tg-cang-MP1595-Ab-2Anti-Canine SLC2A6 monoclonal antibodyCanine
GM-Tg-bovg-MP1595-Ab-1/ GM-Tg-bovg-MP1595-Ab-2Anti-Bovine SLC2A6 monoclonal antibodyBovine
GM-Tg-equg-MP1595-Ab-1/ GM-Tg-equg-MP1595-Ab-2Anti-Equine SLC2A6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1595-Ab-1/ GM-Tg-hg-MP1595-Ab-2; GM-Tg-rg-MP1595-Ab-1/ GM-Tg-rg-MP1595-Ab-2;
GM-Tg-mg-MP1595-Ab-1/ GM-Tg-mg-MP1595-Ab-2; GM-Tg-cynog-MP1595-Ab-1/ GM-Tg-cynog-MP1595-Ab-2;
GM-Tg-felg-MP1595-Ab-1/ GM-Tg-felg-MP1595-Ab-2; GM-Tg-cang-MP1595-Ab-1/ GM-Tg-cang-MP1595-Ab-2;
GM-Tg-bovg-MP1595-Ab-1/ GM-Tg-bovg-MP1595-Ab-2; GM-Tg-equg-MP1595-Ab-1/ GM-Tg-equg-MP1595-Ab-2
Products NameAnti-SLC2A6 monoclonal antibody
Formatmab
Target NameSLC2A6
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC2A6 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GTR6/ SLC2A6/ GLUT6 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001101human SLC2A6 Lentivirus particle
    ORF Viral VectorpGMLP001101human SLC2A6 Lentivirus plasmid
    ORF Viral VectorpGMLPm004945mouse Slc2a6 Lentivirus plasmid
    ORF Viral VectorvGMLPm004945mouse Slc2a6 Lentivirus particle


    Target information

    Target IDGM-MP1595
    Target NameSLC2A6
    Gene ID11182,227659,296600,722199,100855702,101083721,510658,111770625
    Gene Symbol and SynonymsA330096C23,F630103L12Rik,GLUT-6,GLUT6,GLUT9,HSA011372,SLC2A6
    Uniprot AccessionQ9UGQ3
    Uniprot Entry NameGTR6_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000160326
    Target ClassificationN/A

    The target: SLC2A6, gene name: SLC2A6, also named as GLUT6, GLUT9, HSA011372. Hexose transport into mammalian cells is catalyzed by a family of membrane proteins, including SLC2A6, that contain 12 transmembrane domains and a number of critical conserved residues.[supplied by OMIM, Jul 2002].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.